CapsoVision, IncCVEarnings & Financial Report
CapsoVision, Inc. is a medical technology firm specializing in the development and manufacturing of advanced capsule endoscopy systems and supporting diagnostic solutions. Its non-invasive gastrointestinal imaging products are supplied to hospitals, gastroenterology clinics and medical specialists across global markets, supporting more accurate detection of digestive diseases and improved patient care experiences.
Revenue
$3.3M
Gross Profit
$1.8M
Operating Profit
$-4.7M
Net Profit
$-4.6M
Gross Margin
54.6%
Operating Margin
-140.3%
Net Margin
-139.5%
YoY Growth
N/A
EPS
$-2.02
CapsoVision, Inc Q2 FY2025 Financial Summary
CapsoVision, Inc reported revenue of $3.3M for Q2 FY2025, with a net profit of $-4.6M (-139.5% margin). Cost of goods sold was $1.5M, operating expenses totaled $6.5M.
Key Financial Metrics
| Total Revenue | $3.3M |
|---|---|
| Net Profit | $-4.6M |
| Gross Margin | 54.6% |
| Operating Margin | -140.3% |
| Report Period | Q2 FY2025 |
Revenue Breakdown
CapsoVision, Inc Q2 FY2025 revenue of $3.3M breaks down across 2 segments, led by Products at $2.4M (71.0% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $2.4M | 71.0% |
| Other | $962.0K | 29.0% |
CapsoVision, Inc Revenue by Segment — Quarterly Trend
CapsoVision, Inc revenue by segment across the last 2 reported quarters, showing how each business line (such as Products and Other) has evolved quarter over quarter.
| Segment | Q3 FY2025 | Q2 FY2025 |
|---|---|---|
| Products | $2.5M | $2.4M |
| Other | $1.0M | $962.0K |
CapsoVision, Inc Quarterly Revenue & Net Profit History
CapsoVision, Inc results over the last 2 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $3.5M | — | $-7.9M | -223.9% |
| Q2 FY2025 | $3.3M | — | $-4.6M | -139.5% |
Income Statement
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Revenue | $3.3M | $3.5M |
| YoY Growth | N/A | N/A |
Balance Sheet
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Assets | $9.5M | $25.7M |
| Liabilities | $4.9M | $5.2M |
| Equity | $-139.0M | $20.4M |
Cash Flow
| Q2 2025 | Q3 2025 | |
|---|---|---|
| Operating CF | $-9.5M | $-5.7M |